CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Miami, Florida, United States and 72 other locations
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...
Phase 2
Miami, Florida, United States and 76 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Homestead, Florida, United States and 40 other locations
This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...
Phase 4
Boca Raton, Florida, United States of America and 35 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Miami, Florida, United States and 241 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Miami, Florida, United States and 237 other locations
derived human stromal cells, in treating Secondary Progressive Multiple Sclerosis (SPMS), compared to placebo.The study will assess...
Phase 2
Miami, Florida, United States and 1 other location
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...
Phase 3
Miami, Florida, United States and 314 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...
Phase 3
Miami, Florida, United States and 297 other locations
Clinical trials
Research sites
Resources
Legal